Daliresp and Adderall drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Daliresp (roflumilast) and Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate). Common drug interactions include sinusitis among females and sinusitis among males.

The phase IV clinical study analyzes what interactions people have when they take Daliresp and Adderall. It is created by eHealthMe based on reports of 22 people who take the same drugs from the FDA, and is updated regularly.

What is Daliresp?

Daliresp has active ingredients of roflumilast. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 4,722 Daliresp users. Check the latest studies of Daliresp.

What is Adderall?

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 64,224 Adderall users. Check the latest studies of Adderall.

On Jul, 09, 2026

22 people who take Daliresp and Adderall together, and have interactions are studied.

Daliresp and Adderall drug interactions.

What are the common drug interactions of Daliresp and Adderall, by gender? *:

female:

Sinusitis (inflammation of sinus)
Abdominal pain lower
Anxiety
Constipation
Dizziness
Dysuria (painful or difficult urination)
Mass
Urinary tract infection
Vaginal discharge
Back pain

male:

Sinusitis (inflammation of sinus)
Loss of consciousness
Respiratory tract infection
Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Dyspnoea (difficult or laboured respiration)
Haemochromatosis (body to absorb more iron than usual from food)
Head injury
Hepatitis c
Joint swelling
Muscle spasms (muscle contraction)

What are the common drug interactions of Daliresp and Adderall, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Vaginal discharge
Back pain
Fatigue (feeling of tiredness)
Head discomfort
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
Hypoaesthesia (reduced sense of touch or sensation)
Respiratory tract infection
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Axillary pain
Chest discomfort

60+:

Loss of consciousness
Haemochromatosis (body to absorb more iron than usual from food)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 27.27%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 27.27%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 9.09%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Daliresp and Adderall?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously